Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 52 results

research Co-Occurrence of Progressive Hemifacial Atrophy Due to Morphea With Homolateral Segmental Vitiligo: A Case Report

April 2021 in “Authorea (Authorea)”

A 20-year-old woman had stable Progressive Hemifacial Atrophy and Vitiligo after treatment, suggesting a possible link between the conditions.

research Parry-Romberg Syndrome Vasculopathy and Its Treatment With Botulinum Toxin

15 citations, May 2013 in “Ophthalmic Plastic and Reconstructive Surgery”

Botulinum toxin injections greatly reduced pain in Parry-Romberg syndrome.

research The Irish Experience in Pediatric Parry Romberg Syndrome: A Case Series Highlighting Management and Surgical Outcomes

June 2019 in “Abstracts”

Children with Parry Romberg Syndrome had successful facial fat-grafting surgeries after disease stabilization with no complications.

research Parry-Romberg Syndrome Augmented by Hyaluronic Acid Filler

6 citations, January 2018 in “Annals of dermatology/Annals of Dermatology”

Hyaluronic acid filler can safely and effectively improve facial contour in Parry-Romberg Syndrome.

research Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging

132 citations, January 2017 in “International Journal of Molecular Sciences”

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

View more "hemifacial atrophy" in research →

Community Join

1 / 1 results

community No, Finasteride as a treatment for MPB was not an "accident"

in Research/Science 106 upvotes 4 years ago

Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.